Navigation Links
Drug Reduces Risk of Clogged Arteries, Veins

The blood-thinning drug fondaparinux (Arixta) nearly halves the risk of potentially deadly deep vein thrombosis and pulmonary embolism in people hospitalized with congestive heart failure, chronic respiratory disease and other conditions that increase the risk of these conditions, claims a new study.
People treated with the drug were 47 percent less likely to suffer venous thromboembolism (a condition involving clotting or obstruction of a vein that includes both deep vein thrombosis and pulmonary embolism) than people who received a placebo,// according to the study results. In the group taking fondaparinux, 5.6 percent had venus thromboembolism events, compared with 10.5 percent of the people in the placebo group.

The study also found that the drug reduced fatal pulmonary embolisms and showed a trend toward reducing overall death - 3.3 percent in the study group compared with 6 percent in the placebo group. The incidence of bleeding in both groups was 0.2 percent.
'"/>




Page: 1

Related medicine news :

1. Sunshine Reduces MS Risk
2. Estrogen in Food Reduces Cancer Risk
3. Dental Procedure Reduces Preterm Births
4. Vaccine Reduces antibiotic-resistant infections in Children
5. Eating Fiber Reduces The Risk Of Heart Disease
6. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
7. Anti-tobacco Advertising Can Reduces smoking Among Teens
8. Eating Fish Reduces Heart Disease
9. Co-trimoxazole Use Reduces Childhood AIDS –Related Death
10. NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks
11. Oxytocin Boosts Trust and Reduces Fear.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/24/2016)... ... May 24, 2016 , ... ... of communication enabled solutions and managed services today announced a strategic partnership ... enterprise contact center market. , Altura, one of Avaya’s largest Platinum Business ...
(Date:5/24/2016)... ... May 24, 2016 , ... How to Write Error Free ... http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major cause of ... will ever be totally eliminated, many human performance problems can be prevented. , How ...
(Date:5/24/2016)... ... May 24, 2016 , ... Regenerative Medicine is being ... adult stem cell therapy technology, protocols and patient results as have been achieved with ... become a more accessible standard of care for patients worldwide. , As the Medical ...
(Date:5/24/2016)... NY (PRWEB) , ... May 24, 2016 , ... ... treatment for physical disease or injury that focuses on repairing the musculoskeletal and ... , With an emphasis on functional restoration, NYDNRehab began providing treatments for physical ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... A newly ... rely heavily on their access to trusted resources, both in face-to-face interactions and online. ... Men of Color,” researchers concluded that the creative use of mobile digital devices can ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Global Paclitaxel Market ... profiles 12 companies and the Paclitaxel analysis in this ... the industry and its players. This is ... nature, details the current state of the industry while ... classifications, applications and industry chain structure. The Paclitaxel market ...
(Date:5/23/2016)... 2016 Clarifying Vision - Prospects ... and Vision Care What can be expected ... to grow at the fastest rates? This visiongain ... data, trends, opportunities and prospects. ,Our ... the most lucrative areas in the industry and the ...
(Date:5/23/2016)... 2016 Gamida Cell, a leader ... cancer and orphan genetic diseases, announced today it has ... from the Israel Innovation Authority (formerly the Office of ... and Industry. The mission of the Israel Innovation Authority ... including science and technology, while stimulating economic growth. ...
Breaking Medicine Technology: